Pentobarbital versus thiopental in the treatment of refractory intracranial hypertension in patients with traumatic brain injury: a randomized controlled trial

Jon Pérez-Bárcena, Juan A Llompart-Pou, Javier Homar, Josep M Abadal, Joan M Raurich, Guillem Frontera, Marta Brell, Javier Ibáñez, Jordi Ibáñez, Jon Pérez-Bárcena, Juan A Llompart-Pou, Javier Homar, Josep M Abadal, Joan M Raurich, Guillem Frontera, Marta Brell, Javier Ibáñez, Jordi Ibáñez

Abstract

Introduction: Experimental research has demonstrated that the level of neuroprotection conferred by the various barbiturates is not equal. Until now no controlled studies have been conducted to compare their effectiveness, even though the Brain Trauma Foundation Guidelines recommend that such studies be undertaken. The objectives of the present study were to assess the effectiveness of pentobarbital and thiopental in terms of controlling refractory intracranial hypertension in patients with severe traumatic brain injury, and to evaluate the adverse effects of treatment.

Methods: This was a prospective, randomized, cohort study comparing two treatments: pentobarbital and thiopental. Patients who had suffered a severe traumatic brain injury (Glasgow Coma Scale score after resuscitation < or = 8 points or neurological deterioration during the first week after trauma) and with refractory intracranial hypertension (intracranial pressure > 20 mmHg) first-tier measures, in accordance with the Brain Trauma Foundation Guidelines.

Results: A total of 44 patients (22 in each group) were included over a 5-year period. There were no statistically significant differences in ' baseline characteristics, except for admission computed cranial tomography characteristics, using the Traumatic Coma Data Bank classification. Uncontrollable intracranial pressure occurred in 11 patients (50%) in the thiopental treatment group and in 18 patients (82%) in the pentobarbital group (P = 0.03). Under logistic regression analysis--undertaken in an effort to adjust for the cranial tomography characteristics, which were unfavourable for pentobarbital--thiopental was more effective than pentobarbital in terms of controlling intracranial pressure (odds ratio = 5.1, 95% confidence interval 1.2 to 21.9; P = 0.027). There were no significant differences between the two groups with respect to the incidence of arterial hypotension or infection.

Conclusions: Thiopental appeared to be more effective than pentobarbital in controlling intracranial hypertension refractory to first-tier measures. These findings should be interpreted with caution because of the imbalance in cranial tomography characteristics and the different dosages employed in the two arms of the study. The incidence of adverse effects was similar in both groups.

Trial registration: (Trial registration: US Clinical Trials registry NCT00622570.).

Figures

Figure 1
Figure 1
AUC of ICP data. Presented are areas under the curve (AUCs) of the intracranial pressure (ICP) data, standardized by time, with a base value of 20 mmHg.

References

    1. The Brain Trauma Foundation The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Anesthetics, analgesics, and sedatives. J Neurotrauma. 2007;24(suppl 1):S71–S76.
    1. Roberts I. Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev. 2000;2:CD000033.
    1. Almaas R, Saugstad OD, Pleasure D, Rootwelt T. Effect of barbiturates on hydroxyl radicals, lipid peroxidation, and hypoxic cell death in human NT2-N neurons. Anesthesiology. 2000;92:764–774. doi: 10.1097/00000542-200003000-00020.
    1. Cole DJ, Cross LM, Drummond JC, Patel PM, Jacobsen WK. Thiopentone and methohexital, but not pentobarbitone, reduce early focal cerebral ischemic injury in rats. Can J Anaesth. 2001;48:807–814.
    1. Shibuta S, Kosaka J, Mashimo T, Fukuda Y, Yoshiya I. Nitric oxide-induced cytotoxicity attenuation by thiopentone sodium but not pentobarbitone sodium in primary brain cultures. Br J Pharmacol. 1998;124:804–810. doi: 10.1038/sj.bjp.0701884.
    1. Smith DS, Rehncrona S, Siesjo BK. Inhibitory effects of different barbiturates on lipid peroxidation in brain tissue in vitro: comparison with the effects of promethazine and chlorpromazine. Anesthesiology. 1980;53:186–194. doi: 10.1097/00000542-198009000-00002.
    1. The Brain Trauma Foundation The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care. Critical pathway for the treatment of established intracranial hypertension. J Neurotrauma. 2000;17:537–538.
    1. Marshall LF, Marshall SB, Klauber MR, Van Berkum Clark M, Eisenberg H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9:S287–S292.
    1. Servadei F, Murray GD, Penny K, Teasdale GM, Dearden M, Iannotti F, Lapierre F, Maas AJ, Karimi A, Ohman J, Persson L, Stocchetti N, Trojanowski T, Unterberg A. The value of the worst computed tomographic scan in clinical studies of moderate and severe head injury. European Injury Consortium. Neurosurgery. 2000;46:70–75. doi: 10.1097/00006123-200001000-00014.
    1. Eisenberg HM, Frankowski RF, Contant CF, Marshal LF, Walker MD. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg. 1988;69:15–23.
    1. Munch EC, Bauhuf C, Horn P, Roth HR, Schmiedek P, Vajkoczy P. Therapy of malignant intracranial hypertension by controlled lumbar cerebrospinal fluid drainage. Crit Care Med. 2001;29:976–981. doi: 10.1097/00003246-200105000-00016.
    1. Abadal-Centelles JM, Llompart-Pou JA, Homar-Ramirez J, Pérez-Bárcena J, Rosselló-Ferrer A, Ibáñez-Juvé J. Neurologic outcome of posttraumatic refractory intracranial hypertension treated with external lumbar drainage. J Trauma. 2007;62:282–286.
    1. Stocchetti N, Zanaboni C, Colombo A, Citerio G, Beretta L, Ghisoni L, Zanier ER, Canavesi K. Refractory intracraneal hypertension and second tier therapies in traumatic brain injury. Intensive Care Med. 2008;34:461–467. doi: 10.1007/s00134-007-0948-9.
    1. Teasdale GM, Pettigrew LE, Wilson JT, Murray G, Jennett B. Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. J Neurotrauma. 1998;15:587–597.
    1. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990;300:230–235.
    1. Pérez-Bárcena J, Barceló B, Homar J, Abadal JM, Molina FJ, De la Peña A, Sahuquillo J, Ibañez J. Comparision of the effectiveness of pentobarbital and thiopental in patients with refractory intracraneal hypertension. Preliminary report of 20 patients. Neurocirugia (Astur) 2005;16:5–12.
    1. Moreno R, Vincent JL, Matos R, Mendonça A, Cantraine F, Thijs L, Takala J, Sprung C, Antonelli M, Bruining H, Willatts S. The use of SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective multicentre study. Intensive Care Med. 1999;25:686–696. doi: 10.1007/s001340050931.
    1. Ghajar J, Hariri RJ, Narayan RK, Iacono LA, Firlik K, Patterson RH. Survey of critical care management of comatose, head-injured patients in the United States. Crit Care Med. 1995;23:560–567. doi: 10.1097/00003246-199503000-00023.
    1. Jeevaratnam DR, Menon DK. Survey of intensive care of severely head injured patients in the United Kingdom. BMJ. 1996;312:944–947.
    1. Steen PA, Michenfelder JD. Mechanisms of barbiturate protection. Anesthesiology. 1980;53:183–185. doi: 10.1097/00000542-198009001-00183.
    1. Hatano Y, Nakamura K, Moriyama S, Mori K, Toda N. The contractile responses of isolated dog cerebral and extracerebral arteries to oxybarbiturates and thiobarbiturates. Anesthesiology. 1989;71:80–86. doi: 10.1097/00000542-198907000-00015.
    1. Drummond JC, Patel PM, Cole DJ. Cerebral protection: are all barbiturates created equal? Anesthesiology. 1996;85:1504–1505. doi: 10.1097/00000542-199612000-00050.
    1. Roesch C, Haselby KA, Paradise RR, Krishna G, Dierdoff S, Wolfe TM, Rao CC. Comparision of cardiovascular effects of thiopental and pentobarbital at equivalent levels of CNS depression. Anesth Analg. 1983;62:49–53. doi: 10.1213/00000539-198308000-00008.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner